News

ACSESS says that last year, its members, which include established recruiting, executive search, staffing services and ...
PharmAla says its LaNeo MDMA drug products are exclusively available through a qualified practitioner’s prescription and ...
The two companies signed a memorandum of understanding to cooperate on the initiative on May 29, the last day of the CANSEC defence industry trade show in Ottawa.
The economy can grow 0.1 per cent in April despite a forecasted fourth consecutive monthly decline in the manufacturing industry.
Stellantis, the world’s fourth-largest carmaker, named Italian auto executive Antonio Filosa as its new chief executive officer on May 28, replacing Carlos Tavares, who resigned under pressure ...
To mitigate the effects of a potential downturn, business leaders laid out their top priorities for the Canadian government: Remove interprovincial trade barriers and harmonize regulations and ...
Avanti Software says that despite generous funding, government entities continue to procure foreign software, breaking the cycle of domestic investment and reinvestment. CALGARY — David Owen ...
VICTORIA — The Capital Regional District (CRD), working together with FortisBC Energy Inc. (FortisBC) and Waga Energy Canada, has started producing Renewable Natural Gas (RNG) at a new facility ...
Power produced by 49,700 solar photovoltaic panels will supply approximately 7,000 households with electricity and strengthen Alberta's energy grid. COUNTY OF NEWELL — The Canada Infrastructure ...
The FSR is being developed by PyroGenesis for HPQ Silica Polvere, a subsidiary of HPQ Silicon. MONTREAL — PyroGenesis’ independent analysis confirms the material produced during the latest ...
TORONTO — The province announces that it is supporting the creation of a made-in-Ontario critical minerals supply chain that reportedly includes new resources and opportunities for Indigenous ...
A confirmatory Phase III trial (DESTINY-Gastric04) is currently ongoing. MISSISSAUGA — Canada’s Drug Agency has issued a Time-Limited Reimbursement recommendation for ENHERTU (trastuzumab ...